SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer.

[1]  N. Clarke,et al.  Identification and evaluation of clinically significant prostate cancer: a step towards personalized diagnosis , 2017, Current opinion in urology.

[2]  C. Zhu,et al.  Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway , 2017, Oncotarget.

[3]  Mingang Ying,et al.  Expression of Long Non-Coding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) Exacerbates Hepatocellular Carcinoma Through Suppressing miR-195 , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[4]  Shu Yang,et al.  Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer , 2016, Oncotarget.

[5]  H. Juan,et al.  Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma , 2016, Oncotarget.

[6]  Tao Yang,et al.  miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells , 2016, Oncotarget.

[7]  Min Zhang,et al.  Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  A. C. Marques,et al.  miRNA‐mediated crosstalk between transcripts: The missing “linc”? , 2016, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  Dong Wang,et al.  Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives , 2016, Oncotarget.

[10]  Melissa J. Fullwood,et al.  Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer , 2016, Genom. Proteom. Bioinform..

[11]  A. Partin,et al.  Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer , 2015, Prostate Cancer and Prostatic Disease.

[12]  Chengping Hu,et al.  Competing endogenous RNA in cancer: a new pattern of gene expression regulation. , 2015, International journal of clinical and experimental medicine.

[13]  Wang Ma,et al.  ceRNA in cancer: possible functions and clinical implications , 2015, Journal of Medical Genetics.

[14]  T. Sun,et al.  MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway , 2015, Tumor Biology.

[15]  M. Malumbres,et al.  Cyclin-dependent kinases , 2014, Genome Biology.

[16]  M. Borrello,et al.  miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma , 2014, Oncotarget.

[17]  Qinghua Zhou,et al.  Noncoding RNA small nucleolar RNA host gene 1 promote cell proliferation in nonsmall cell lung cancer. , 2014, Indian journal of cancer.

[18]  P. Pandolfi,et al.  The multilayered complexity of ceRNA crosstalk and competition , 2014, Nature.

[19]  A. Fatica,et al.  Long non-coding RNAs: new players in cell differentiation and development , 2013, Nature Reviews Genetics.

[20]  Xuefei Shi,et al.  Long non-coding RNAs: a new frontier in the study of human diseases. , 2013, Cancer letters.

[21]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[22]  H. Mankin,et al.  MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration , 2011, Molecular Cancer Therapeutics.

[23]  Phillip A. Sharp,et al.  Emerging Roles for Natural MicroRNA Sponges , 2010, Current Biology.

[24]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[25]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[26]  Longke Ran,et al.  Identification of prostate cancer LncRNAs by RNA-Seq. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[27]  W. Zhai,et al.  Transcriptome profiling of prostate tumor and matched normal samples by RNA-Seq. , 2014, European review for medical and pharmacological sciences.